 Beta-adrenergic blocker therapy intermittent claudication subjects peripheral arterial disease meta-analysis controlled trials Beta-Adrenergic blockers peripheral arterial disease risk drugs intermittent claudication meta-analysis available trials English-language literature beta-blockers intermittent claudication primary focus analysis effect beta-blockers exercise duration capacity endurance time Outcomes appropriate eligible reports individual treatment comparisons data analysis pain-free exercise capacity effect size significant pooled effect size pain-free walking distance confidence interval significant impairment capacity placebo study certain beta-blockers worsening intermittent claudication results beta-blockers affect capacity symptoms intermittent claudication patients mild peripheral arterial disease absence contraindications beta-blockers patients